Recent progress in fucosylated derivatives of lacto-N-tetraose and lacto-N-neotetraose

• Published in: Critical reviews in food science and nutrition 2024-11, Vol.64 (28), p.10384-10396
• Main Authors: Yang, Longhao, Zhu, Yingying, Meng, Jiawei, Zhang, Wenli, Mu, Wanmeng
• Format: Article
• Language: English
• Subjects: Antibacterial activity; Biological effects; Biosynthesis; Breast milk; Chemical bonds; Fucose - chemistry; fucosylated derivatives; Gastrointestinal Microbiome - drug effects; Human milk oligosaccharides; Humans; Immunomodulation; Infant Formula - chemistry; Infant formulas; Intestinal microflora; Milk, Human - chemistry; occurrence; Oligosaccharides; Oligosaccharides - chemistry; Oligosaccharides - pharmacology; Physiological effects; Physiology
• ISSN: 1040-8398; 1549-7852; 1549-7852
• DOI: 10.1080/10408398.2023.2224431

Human milk oligosaccharides (HMOs) have attracted considerable attention owing to their unique physiological functions. Two important tetrasaccharides, lacto-N-tetraose (LNT) and lacto-N-neotetraose (LNnT), are core structures of HMOs. Their safety has been evaluated and they can be added to infant formula as functional ingredients. The fucosylated derivatives of LNT and LNnT, mainly lacto-N-fucopentaose (LNFP) I, LNFP II, LNFP III, and lacto-N-difucohexaose I, exhibit prominent physiological characteristics, including modificating the intestinal microbiota, immunomodulation, anti-bacterial activities, and antiviral infection. However, they have received lesser attention than 2'-fucosyllactose. As precursors, LNT and LNnT are connected to one or two fucosyl units through α1,2/3/4 glycosidic bonds, forming a series of compounds with complex structures. These complex fucosylated oligosaccharides can be biologically synthesized using enzymatic and cell factory approaches. This review summarizes the occurrence, physiological effects, and biosynthesis of fucosylated LNT and LNnT derivatives and their future development.